POMELLA Extract Gains Australian TGA Approval
A substantial amount of published research supports the use of natural-spectrum pomegranate fruit extracts for cardiovascular and cellular health with none of the sugar, calories, or polyphenol inconsistency of pomegranate juice.
15/08/07 Verdure Sciences has announced that POMELLA Extract, the clinically researched natural spectrum pomegranate extract standardized to punicalagins, has been granted approval for use in complementary medicine products in Australia by the Therapeutic Goods Administration (TGA).
The approval arrives during increasing consumer awareness of pomegranate’s health benefits, particularly pomegranate extracts.
A substantial amount of published research supports the use of natural-spectrum pomegranate fruit extracts for cardiovascular and cellular health—as well as several other targeted health issues—with none of the sugar, calories, or polyphenol inconsistency of pomegranate juice.
“With all the recent interest in the tangible health benefits pomegranate can offer, we are excited that POMELLA Extract is now TGA approved and available to Australian and New Zealand customers through our close relationship with Pathway International,” said Blake Ebersole, Technical Director of Verdure Sciences.
